A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"Hashtag": "as:Hashtag"
}
],
"id": "https://techhub.social/users/mfauscette/statuses/114519520501133214",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2025-05-16T21:00:06Z",
"url": "https://techhub.social/@mfauscette/114519520501133214",
"attributedTo": "https://techhub.social/users/mfauscette",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://techhub.social/users/mfauscette/followers"
],
"sensitive": false,
"atomUri": "https://techhub.social/users/mfauscette/statuses/114519520501133214",
"inReplyToAtomUri": null,
"conversation": "tag:techhub.social,2025-05-16:objectId=265161133:objectType=Conversation",
"content": "<p>This AI-designed drug for IBD was just given to human subjects for the first time. Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.<br /><a href=\"https://zurl.co/Oktif\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"\">zurl.co/Oktif</span><span class=\"invisible\"></span></a><br /><a href=\"https://techhub.social/tags/ai\" class=\"mention hashtag\" rel=\"tag\">#<span>ai</span></a> <a href=\"https://techhub.social/tags/airesearch\" class=\"mention hashtag\" rel=\"tag\">#<span>airesearch</span></a> <a href=\"https://techhub.social/tags/biotech\" class=\"mention hashtag\" rel=\"tag\">#<span>biotech</span></a></p>",
"contentMap": {
"en": "<p>This AI-designed drug for IBD was just given to human subjects for the first time. Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.<br /><a href=\"https://zurl.co/Oktif\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"\">zurl.co/Oktif</span><span class=\"invisible\"></span></a><br /><a href=\"https://techhub.social/tags/ai\" class=\"mention hashtag\" rel=\"tag\">#<span>ai</span></a> <a href=\"https://techhub.social/tags/airesearch\" class=\"mention hashtag\" rel=\"tag\">#<span>airesearch</span></a> <a href=\"https://techhub.social/tags/biotech\" class=\"mention hashtag\" rel=\"tag\">#<span>biotech</span></a></p>"
},
"attachment": [],
"tag": [
{
"type": "Hashtag",
"href": "https://techhub.social/tags/AI",
"name": "#AI"
},
{
"type": "Hashtag",
"href": "https://techhub.social/tags/airesearch",
"name": "#airesearch"
},
{
"type": "Hashtag",
"href": "https://techhub.social/tags/biotech",
"name": "#biotech"
}
],
"replies": {
"id": "https://techhub.social/users/mfauscette/statuses/114519520501133214/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://techhub.social/users/mfauscette/statuses/114519520501133214/replies?only_other_accounts=true&page=true",
"partOf": "https://techhub.social/users/mfauscette/statuses/114519520501133214/replies",
"items": []
}
},
"likes": {
"id": "https://techhub.social/users/mfauscette/statuses/114519520501133214/likes",
"type": "Collection",
"totalItems": 1
},
"shares": {
"id": "https://techhub.social/users/mfauscette/statuses/114519520501133214/shares",
"type": "Collection",
"totalItems": 0
}
}